Sp1-mediated microRNA-182 expression regulates lung cancer progression

Wen Bin Yang, Ping Hsin Chen, Tsung I. Hsu, Tzu Fun Fu, Wu Chou Su, Hungjiun Liaw, Wen Chang Chang, Jan Jong Hung

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.

Original languageEnglish
Pages (from-to)740-753
Number of pages14
JournalOncotarget
Volume5
Issue number3
Publication statusPublished - 2014

Fingerprint

MicroRNAs
Lung Neoplasms
Neoplasm Metastasis
Neoplasms
Growth
3' Untranslated Regions
Cadherins
Lung
Messenger RNA
Genes
Proteins

Keywords

  • FOXO3
  • Lung cancer
  • MiR-182
  • Sp1

ASJC Scopus subject areas

  • Oncology
  • Medicine(all)

Cite this

Yang, W. B., Chen, P. H., Hsu, T. I., Fu, T. F., Su, W. C., Liaw, H., ... Hung, J. J. (2014). Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget, 5(3), 740-753.

Sp1-mediated microRNA-182 expression regulates lung cancer progression. / Yang, Wen Bin; Chen, Ping Hsin; Hsu, Tsung I.; Fu, Tzu Fun; Su, Wu Chou; Liaw, Hungjiun; Chang, Wen Chang; Hung, Jan Jong.

In: Oncotarget, Vol. 5, No. 3, 2014, p. 740-753.

Research output: Contribution to journalArticle

Yang, WB, Chen, PH, Hsu, TI, Fu, TF, Su, WC, Liaw, H, Chang, WC & Hung, JJ 2014, 'Sp1-mediated microRNA-182 expression regulates lung cancer progression', Oncotarget, vol. 5, no. 3, pp. 740-753.
Yang WB, Chen PH, Hsu TI, Fu TF, Su WC, Liaw H et al. Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget. 2014;5(3):740-753.
Yang, Wen Bin ; Chen, Ping Hsin ; Hsu, Tsung I. ; Fu, Tzu Fun ; Su, Wu Chou ; Liaw, Hungjiun ; Chang, Wen Chang ; Hung, Jan Jong. / Sp1-mediated microRNA-182 expression regulates lung cancer progression. In: Oncotarget. 2014 ; Vol. 5, No. 3. pp. 740-753.
@article{83d84d80a07e417d9fc72febab1d4c73,
title = "Sp1-mediated microRNA-182 expression regulates lung cancer progression",
abstract = "Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.",
keywords = "FOXO3, Lung cancer, MiR-182, Sp1",
author = "Yang, {Wen Bin} and Chen, {Ping Hsin} and Hsu, {Tsung I.} and Fu, {Tzu Fun} and Su, {Wu Chou} and Hungjiun Liaw and Chang, {Wen Chang} and Hung, {Jan Jong}",
year = "2014",
language = "English",
volume = "5",
pages = "740--753",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "3",

}

TY - JOUR

T1 - Sp1-mediated microRNA-182 expression regulates lung cancer progression

AU - Yang, Wen Bin

AU - Chen, Ping Hsin

AU - Hsu, Tsung I.

AU - Fu, Tzu Fun

AU - Su, Wu Chou

AU - Liaw, Hungjiun

AU - Chang, Wen Chang

AU - Hung, Jan Jong

PY - 2014

Y1 - 2014

N2 - Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.

AB - Our recent study indicated that overexpression of Sp1 enhances the proliferation of lung cancer cells, while represses metastasis. In this study, we found that the transcriptional activity of FOXO3 was increased, but its protein levels decreased following Sp1 expression. Sp1 increased expression of miR-182, which was then recruited to the 3'-untranslated region of FOXO3 mRNA to silence its translational activity. Knockdown of miR-182 inhibited lung cancer cells growth, but enhanced the invasive and migratory abilities of these cells through increased N-cadherin expression. Repression of FOXO3 expression in the miR-182 knockdown cells partially reversed this effect, suggesting that miR-182 promotes cancer cell growth and inhibits cancer metastatic activity by regulating the expression of FOXO3. The expression of several cancer metastasis-related genes such as ADAM9, CDH9 and CD44 was increased following miR-182 knockdown. In conclusion, in the early stages of lung cancer progression, Sp1 stimulates miR-182 expression, which in turn decreases FOXO3 expression. This stimulates proliferation and tumor growth. In the late stages, Sp1 and miR-182 decline, thus increasing FOXO3 expression, which leads to lung metastasis.

KW - FOXO3

KW - Lung cancer

KW - MiR-182

KW - Sp1

UR - http://www.scopus.com/inward/record.url?scp=84896844569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896844569&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 740

EP - 753

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 3

ER -